Ken Griffin’s DNA X Inc SONM Stock Holding History

Ken Griffin’s Portfolio SONM Stock Details SONM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-35	Closed	-$35K	–	14591
2021 Q2	$35K	Buy	35 +24	+218%	+$26.1K	﹤0.01%	13451
2021 Q1	$17K	Buy	+11	New	+$19.4K	﹤0.01%	13077

Other funds holding SONM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DAS

Dynamic Advisor Solutions Phoenix, Arizona $3.53B AUM 22.61% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

Ken Griffin's SONM Position: Q3 2021 in Review

Ken Griffin sold out of DNA X Inc (SONM) in Q3 2021, closing a stake of 35 shares — an estimated $35K sold.

Ken Griffin first reported a position in SONM in Q1 2021 and held it in 2 quarters. The position peaked at $35K in Q2 2021. 11 funds tracked by Wall St. Rank hold SONM as of Q3 2021.

Ken Griffin reported no remaining DNA X Inc position as of Q3 2021 after selling out during the quarter.
Ken Griffin sold 35 DNA X Inc shares in Q3 2021, an estimated $35K.
Ken Griffin first reported a position in DNA X Inc in Q1 2021 and held it in 2 quarters.
Ken Griffin's DNA X Inc position peaked at $35K in Q2 2021.
11 funds tracked by Wall St. Rank held DNA X Inc as of Q3 2021.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.